Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis

Published:2024-07-01 Issue:13 Volume:8 Page:3555-3559
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Reynolds Gemma K.¹²³⁴^ORCID,Maclean Marsali⁵^ORCID,Cliff Edward R. Scheffer⁶⁷^ORCID,Teh Benjamin W.¹²³^ORCID,Thursky Karin A.¹²³^ORCID,Slavin Monica A.¹²³^ORCID,Anderson Mary Ann⁸⁹^ORCID,Hawkes Eliza A.⁵¹⁰¹¹^ORCID

Affiliation:

1. 1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

2. 2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia

3. 3National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

4. 4Department of Infectious Diseases, Austin Health, Melbourne, VIC, Australia

5. 5Department of Clinical Hematology, Austin Health, Melbourne, VIC, Australia

6. 6Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, MA

7. 7Harvard Medical School, Boston, MA

8. 8Department of Clinical Hematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia

9. 9Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute, Melbourne, VIC, Australia

10. 10Olivia Newton John Cancer Research Centre, Austin Health, Melbourne, VIC, Australia

11. 11Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia

Publisher

American Society of Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/13/3555/2233817/blooda_adv-2024-012916-main.pdf

Reference25 articles.

1. Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis;Reynolds;Blood Adv,2023

2. US Food and Drug Administration . Bispecific antibodies: an area of research and clinical applications. Accessed 10 September 2023. https://www.fda.gov/drugs/news-events-human-drugs/bispecific-antibodies-area-research-and-clinical-applications.

3. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews;Page;BMJ,2021

4. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool;Munn;JBI Evid Synth,2020

5. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas;Blood Advances;2024-09-10

2. Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma;Open Forum Infectious Diseases;2024-08-08